期刊文献+

含C-src同源序列的酪氨酸磷酸酶SHP-2和SHP-1在前列腺增生组织重构中的表达

Expression of tyrosine phosphatase containing C-src homology SH-2 in benign prostate hyperplasia
下载PDF
导出
摘要 目的:探讨含C-src同源序列的酪氨酸磷酸酶SHP-2和SHP-1在前列腺增生组织重构中的表达及意义。方法:采用免疫组化En Vision二步法检测10例正常前列腺组织、30例良性前列腺增生组织(BPH)、20例前列腺上皮内瘤变(PIN)、20例高分化前列腺癌(Pca)和10例低分化前列腺癌组织中SHP-2和SHP-1的表达。结果:SHP-2在正常组中主要表达在基底和上皮细胞的胞浆中,少数在胞核中表达;在BPH组中基底和上皮细胞的胞浆和胞核中均有表达;在PIN、高分化Pca和低分化Pca组中主要在细胞核内表达,少数在胞浆中表达。SHP-2在各组的平均染色指数分别为0.4、1.7、2.1、2.2和2.6。SHP-1在正常前列腺组织,BPH、PIN和高分化Pca的组织细胞的胞浆中均有不同程度表达,在低分化Pca组织中不表达;SHP-1在各组的平均染色指数分别为1.8、1.8、1.5、1.2和0.4。结论:在前列腺组织细胞增殖、分化及转化过程中,存在SHP-1和SHP-2相关的信号传导的改变。SHP-2异常激活和表达部位的改变可能是导致前列腺组织重构、增生及癌变的重要机制。 Objective: To explore the expression of tyrosine phosphatase containing C-src homology SH-2 (SHP-1 and SHP-2) in benign prostate hyperplasia. Methods: With En Vision two-step method,the expression of SHP-1 and SHP-2 was detetecd in 10 cases of normal prostate tissue, 30 cases of BPH, 20 cases of PIN, 20 cases of high differential Pca and 20 cases of low differential Pca. Results: The expression of SHP-2 in normal group was mainly distributed in the cytoplasm of secretive cells and basal cells, and a little part in the nucleu. In BPH it was distributed equally in the plasm and nucleu. In PIN ,high differential Pca and low differential Pca, SHP-2 expressed mainly in nucleu. The average dyeing index of SHP-2 in each group is 0.4,1.7,2. 1,2. 2 and 2. 6. SHP-1 positive expression in normal prostate,BPH, PIN and high differential Pea showed differentiating layer staining in the cytoplasm of secretive cells and basal cells,while not in low differential Pea. The average dyeing index of SHP-1 in each group is 1.8,1.8,1.5,1.2 and 0.4. Conclusions. There are transformation in signal transduction relation with SHP-1 and SHP-2 in the progress of prostate cell proliferation,differentiation and malignant. The abnormal activation and distribution of SHP-2 might induce prostate reconstruction and hyperplasia,even carcinoma.
出处 《浙江大学学报(医学版)》 CAS CSCD 2007年第5期488-492,共5页 Journal of Zhejiang University(Medical Sciences)
关键词 前列腺增生/病理学 前列腺肿瘤/病理学 癌前状态/病理学 免疫组织化学 蛋白质酪氨酸磷酸酶 Prostatic hyperplasia/pathol Prostatic neoplasms/pathol Precancerous conditions/pathol Immunohistochemistry Protein-tyrosine-phosphatase
  • 相关文献

参考文献13

  • 1GU Fang-liu (顾方六).Modern Prostatism(现代前列腺病学)[M].Beijing:People's Military Medical Press,2003:153-162.
  • 2FENG Gen-sheng.Shp-2 tyrosine phosphatase:signaling one cell or many.[J].Experimental Cell Research,1999,253(1):47-54.
  • 3ALI S,NOUGHI Z,CHUGHTAI N,et al.SHP-2 regulates SOCS-1 mediated Janus Kinase-2 ubiquitanation/degration downstream of the prolaction receptor[J].J Biol Chem,2003,278(52):52021-52031.
  • 4CORBEL M,BOICHOT E,LAGENTE V.Role of gelatinases MMP-2 and MMP-9 in tissue remodeling following acute lung injury[J].Med Biol Res,2000,33(7):749-754.
  • 5GUILLEMOT L,LEVY A,ZHAO Z J,et al.The protein-tyrosine phosphatase SHP-2 is required during angiotensin Ⅱ-mediated activa-tion of cyclin D1 promoter in CHO-AT1A cells[J].Biol Chem,2000,275(34):26349-26358.
  • 6SU M W,YU C L,BURAKOFF S J,et al.Targeting Src homology 2 domain-containing tyrosine phosphatase (SHP-1) into lipid rafts inhibits CD3-induced T cell activation[J].Immumol,2001,166(3):3975-3982.
  • 7TARTAGLIA M,NIEMEYER C M,SHANSNNON K M,et al.SHP-2 and myeloid malignancies[J].Curr Opin Hematol,2004,11(1):44-50.
  • 8KAPOOR G S,ZHAN Y,JOHNSON G R,et al.Distinct domains in the SHP-2 phophatase differentially regulate epidermal growth factor receptor/NF-Kappa B activation through Gab1 in glioblastoma cells[J].Mol Cell Biol,2004,24(2):823-836.
  • 9CHRISTIANE R,MONICA A,MARINA H M,et al.The tyrosine phosphatase SHP-2 is required for sustained activation of extracellular signal-regulated kinase and epithelial morphogenesis downstream from the Met receptor tyrosine kinase[J].Molecular and Cellular Biology,2000,22(20):8513-8525.
  • 10ZAPATA P D,ROPERO R M,VALENCIA A M,et al.Autocrine regulation of human prostate carcinoma cell proliferation by somatostatin through the modulation of the SH2 domain containing protein tyrosine phosphatase (SHP)-1[J].The Journal of Clinical Endocrinology & Metabolism,2002,87(2):915-926.

二级参考文献20

  • 1Fang WG, Pirnia F, Bang YJ, et al. P2-purinergic receptor agonists inhibit the growth of androgen-independent prostate carcinoma cells. J Clin Invest, 1992,89:191-196.
  • 2Neel BG. Structure and function of SH2-domain containing tyrosine phosphatases. Semin Cell Biol, 1993,4:419-432.
  • 3Duchene J, Schanstra JP, Pecher C. A novel protein-protein interaction between a G protein-coupled receptor and phosphatase SHP-2 is involved in bradykinin-induced inhibition of cell proliferation. J Biol Chem, 2002, 277:40375-40383.
  • 4Tanoue T,Moriguchi T,Nishida E,et al. Molecular cloning and characterization of a novel dual specificity phosphatase,MKP-5. J Biol Chem, 1999,274:19949-19956.
  • 5Lyon MA,Ducruet AP,Wipf P,et al. Dual-specificity phosphatases as targets for antineoplastic agents. Nat Rev Drug Discov, 2002,1:961-976.
  • 6Aoki Y,Huang Z,Thomas SS,et al. Increased susceptibility to ischemia-induced brain damage in transgenic mice overexpressing a dominant negative form of SHP2. FASEB J, 2000,14:1965-1973.
  • 7Albini A,Iwamoto Y,Kleinman HK,et al. A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res, 1987,47:3239-3245.
  • 8Chen L, He HY, Li HM, et al. ERK1/2 and p38 pathways are required for P2Y receptor-mediated prostate cancer invasion. Cancer Lett, 2004,215:239-247.
  • 9Theodosiou A, Smith A,Gillieron C,et al. MKP5,a new member of the MAP kinase phosphatase family,which selectively dephosphorylates stress-activated kinases. Oncogene, 1999,18:6981-6988.
  • 10Zhang SQ, Yang W, Kontaridis MI, et al. Shp2 regulates SRC family kinase activity and Ras/Erk activation by controlling Csk recruitment. Mol Cell, 2004, 13: 341-355.

共引文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部